In conclusion, these findings underscore the multifaceted role of RIP1 in metabolism, inflammation, and cell death regulation, highlighting its potential as a therapeutic target for mitigating metabolic disorders related to obesity. The gene discussed is RIPK1; the disease is obesity disorder.